Morning Momentum Movers:

Cubist Pharmaceuticals, Inc. (Nasdaq: CBST) is 16% higher after the company announced that the FDA has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE